Combination of Magnetic Resonance Spectroscopy and 11C-methionine PET in Early Diagnosis of Non-enhancing Supratentorial Glioma

Kudulaiti Nijiati,Cheng-jun YAO,Tian-ming QIU,Jun-feng LU,Hui-wei ZHANG,Zheng-wei ZHANG,Yang WANG,Dong-xiao ZHANG,Yi-hui GUAN,Jin-song WU
DOI: https://doi.org/10.3969/j.issn.1008-0678.2017.03.002
2017-01-01
Abstract:Aim To investigate whether the combination of magnetic resonance spectroscopy (MRS) and11C-methionine positron emission tomography (11C-MET PET) can increase the true positive rate of early diagnosis of non-enhancing supratentorial gliomas.Methods 65 patients with non-enhancing supratentorial lesions which were confirmed to be gliomas by surgery were enrolled in this study. Each patient underwent both MRS imaging and11C-MET PET scan prior to surgery. The lesion was considered as a glioma when either MRS or11C-MET PET results indicated the diagnosis [maximum Cho/NAA index (CNImax) higher than 2.0 in MRS or tumor versus normal tissue ratio (T/N ratio) higher than 1.3 in 11C-MET PET]. The results of metabolic evaluation were compared with the pathologic diagnosis.Results The true positive rate of MRS imaging was 60.0%, the true positive rate of11C-MET PET was 78.5%. When combining the two examinations, 89.2% of patients were presumed to have gliomas by imaging diagnosis prior to surgery. The difference between the combination of the two examinations and the single examination was statistically signiifcant (P<0.05).Conclusion The combination of MRS and11C-MET PET can significantly elevate the true positive rate of early diagnosis of non-enhancing supratentorial gliomas, which is suitable and promising in clinical applications.
What problem does this paper attempt to address?